T1	Participants 646 787	Between 1999 and 2002, 1397 antiretroviral-treatment-naive patients, presenting at 18 clinical trial units with 80 research sites in the USA,
T2	Participants 1479 1533	1397 patients were assessed for the composite endpoint
T3	Participants 1546 1638	388 participants developed the composite endpoint, 302 developed AIDS or died, and 188 died.
